Amrubicin(R) Receives FDA Orphan Drug Designation For The Treatment Of Small Cell Lung Cancer (Medical News Today)
Celgene Corporation (NASDAQ: CELG) announced that Amrubicin has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer.

FDA Investigates Safety Of Asthma Drug Singulair (Medical News Today)
The US Food and Drug Administration (FDA) is reviewing the safety of Merck & Co's anti-asthma drug Singulair (montelukast) following reports querying a potential link between the drug's use and changes to behaviour and mood, suicide, and suicidal thinking and behaviour.

ARCALYST(TM), First And Only FDA-approved Treatment For Cryopyrin-Associated Periodic Syndromes (CAPS), Now Available ... (Medical News Today)
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced ARCALYST (rilonacept) Injection for Subcutaneous Use is now available for prescription in the United States for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 and older.